Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sidney Sechio"'
Autor:
Colette Owens, Allison P. Jacob, Jade Ruiters, Sidney Sechio, Audrey Hamilton, Clare Grieve, Puja Chadha, Mikhail Roshal, Tak Takvorian, Daneal Portman, Anthony R. Mato, Krista J Scorsune, Jason Carter, Ahmet Dogan, Lauren Ramos, Ai Ni, Natascha Nolet, Juliana M.L. Biondo, Jane Huang, Ephraim P. Hochberg, Anita Kumar, Stephanie Hughes, Morgan Choma, M. Lia Palomba, Rosalba Martignetti, Ariela Noy, Jeffrey A. Barnes, Meghan C. Thompson, P. Connor Johnson, Jeremy S. Abramson, Connie Lee Batlevi, Julia M Lynch, Qun Wu, Chaya Friedman, Erel Joffe, Joanna Mi, Brianne McGree, Elizabeth Simkins, Venkatraman E. Seshan, Matthew J. Matasar, Kelsey Flaherty, Omar Abdel-Wahab, Lindsey E. Roeker, Andrew D. Zelenetz, Jacob D. Soumerai, Neena Mahajan
Publikováno v:
The Lancet Haematology. 8:e879-e890
Summary Background We hypothesised that combining zanubrutinib with obinutuzumab and venetoclax (BOVen) as an initial therapy for chronic lymphocytic leukaemia and small lymphocytic lymphoma would lead to high rates of undetectable minimal residual d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdf7327afd36fee111882d955455bfdf
https://doi.org/10.1016/s2352-3026(21)00307-0
https://doi.org/10.1016/s2352-3026(21)00307-0
Autor:
J. Erika Haydu, Jenny S. Maron, Robert A. Redd, Kathleen M. E. Gallagher, Stephanie Fischinger, Jeffrey A. Barnes, Ephraim P. Hochberg, P. Connor Johnson, R. W. Takvorian, Katelin Katsis, Daneal Portman, Jade Ruiters, Sidney Sechio, Mary Devlin, Connor Regan, Kimberly G. Blumenthal, Aleena Banerji, Allen D. Judd, Krista J. Scorsune, Brianne M. McGree, Maryanne M. Sherburne, Julia M. Lynch, James I. Weitzman, Matthew Lei, Camille N. Kotton, Anand S. Dighe, Marcela V. Maus, Galit Alter, Jeremy S. Abramson, Jacob D. Soumerai
Publikováno v:
Blood Advances
Chronic lymphocytic leukemia (CLL), the most common leukemia worldwide, is associated with increased COVID-19 mortality. Previous studies suggest only a portion of vaccinated CLL patients develop severe acute respiratory syndrome coronavirus 2 (SARS-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc4c1c6e9ae3cc3fe0f6015b073f93fa
https://pubmed.ncbi.nlm.nih.gov/35073571
https://pubmed.ncbi.nlm.nih.gov/35073571
Autor:
Jeffrey A. Barnes, Jenny Wu, Anita A Kumar, Krista J Scorsune, Allison P. Jacob, Jade Ruiters, Connie Lee Batlevi, Rosalba Martignetti, Chaya Friedman, Venkatraman E. Seshan, Daneal Portman, Audrey Hamilton, Ai Ni, Anthony R. Mato, Morgan Choma, Meghan C. Thompson, Clare Grieve, Jane Huang, Elizabeth Simkins, Ahmet Dogan, Tak Takvorian, Jason Carter, Brianne McGree, Colette Owens, Julia M Lynch, Ariela Noy, Puja Chadha, Sidney Sechio, Mikhail Roshal, Erel Joffe, Joanna Mi, M. Lia Palomba, Kelsey Flaherty, Lindsey E. Roeker, Natascha Nolet, Andrew D. Zelenetz, Stephanie Hughes, P. Connor Johnson, Matthew J. Matasar, Omar Abdel-Wahab, Jacob D. Soumerai, Juliana M.L. Biondo, Neena Mahajan, Ephraim P. Hochberg, Jeremy S. Abramson
Publikováno v:
Blood. 138:3753-3753
Background: Venetoclax (Ven; BH3 mimetic) and Obinutuzumab (O; CD20 antibody) is an approved, fixed-duration regimen (one year) that induces undetectable minimum residual disease (uMRD) and durable remissions in treatment naïve patients (pts) with c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7655bd9ce25ab3178eacf658c568de1
https://doi.org/10.1182/blood-2021-150961
https://doi.org/10.1182/blood-2021-150961
Autor:
Anita Kumar, Jacob D. Soumerai, Jeremy S. Abramson, Connie Lee Batlevi, Puja Chadha, Ahmet Dogan, Lorenzo Falchi, Kelsey Flaherty, Chaya Friedman, Clare Grieve, Caleb Ho, P. Connor Johnson, Ashlee Joseph, Niloufer Khan, Joanna Mi, Rosalba Martignetti, Matthew J. Matasar, Colette Owens, Jade Ruiters, Sidney Sechio, Venkatraman Seshan, Elizabeth Simkins, Omar Abdel-Wahab, Andrew D. Zelenetz
Publikováno v:
Blood. 138:3540-3540
Background: TP53 mutant mantle cell lymphoma (MCL) is associated with poor survival outcomes with chemoimmunotherapy (Eskelund Blood 2017) and there is no standard frontline treatment for this high-risk patient population. The combination of Bruton's
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::952d2b1a0bb259448ab2df4d531d4d21
https://doi.org/10.1182/blood-2021-151831
https://doi.org/10.1182/blood-2021-151831